Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Diabetes Care

• Publication date

  2018-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc17-2062PMID 29487078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention

  2017cited by this paper
• Symptoms and the body: Taking the inferential leap

  2017cited by this paper
• Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

  2017cited by this paper
• Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.

  2016cited by this paper
• Diabetic Neuropathy: A Position Statement by the American Diabetes Association

  2016cited by this paper
• Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study

  2016cited by this paper
• Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies.

  2016cited by this paper
• Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status

  2016cited by this paper
• Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study

  2015cited by this paper
• Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

  2015cited by this paper
• The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study

  2015cited by this paper
• Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)

  2015cited by this paper
• Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome

  2015cited by this paper
• Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

  2014cited by this paper
• Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes

  2014cited by this paper
• Epidemiology of polyneuropathy in diabetes and prediabetes.

  2014cited by this paper
• Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials

  2014cited by this paper
• Effect of Early Multifactorial Therapy Compared With Routine Care on Microvascular Outcomes at 5 Years in People With Screen-Detected Diabetes: A Randomized Controlled Trial

  2014cited by this paper
• Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

  2012cited by this paper
• Methylglyoxal Activates Nociceptors through Transient Receptor Potential Channel A1 (TRPA1)

  2012cited by this paper
• Diabetic neuropathy: one disease or two?

  2012cited by this paper
• ENHANCED GLUCOSE CONTROL FOR PREVENTING AND TREATING DIABETIC NEUROPATHY

  2012cited by this paper
• Methylglyoxal activates the human transient receptor potential ankyrin 1 channel.

  2012cited by this paper
• CLONAZEPAM FOR NEUROPATHIC PAIN AND FIBROMYALGIA IN ADULTS

  2012cited by this paper
• Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy

  2012cited by this paper
• Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

  2012cited by this paper
• Diabetic neuropathy: clinical manifestations and current treatments.

  2012cited by this paper
• Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in PeopleWith Screen-Detected Type 2 Diabetes The ADDITION-Denmark study

  2011cited by this paper
• Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in People With Screen-Detected Type 2 Diabetes

  2011cited by this paper
• Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

  2011cited by this paper
• Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

  2010cited by this paper
• The global burden of diabetes and its complications: an emerging pandemic

  2010cited by this paper
• Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study

  2008cited by this paper
• Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy

  2008cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening

  2000cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

  1994cited by this paper
• The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort

  1993cited by this paper
• The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene.

  1992cited by this paper
• [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)].

  1977cited by this paper

• MiR-210-3p is upregulated in diabetic peripheral neuropathy and may be involved in the progression of the disease by targeting brain-derived neurotrophic factor.

  2026cites this paper
• Lower-limb joint moments during gait in individuals with diabetes with and without peripheral neuropathy – A systematic review with meta-analysis

  2026cites this paper
• [Diabetic neuropathy and its relationship with quality of life in patients with type 2 diabetes].

  2026cites this paper
• Glial Triad in Diabetic Neuropathy: Central Players in Neuropathic Pain Pathogenesis and Disease-Modifying Therapeutic Avenues.

  2026cites this paper
• Correlation between lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: A cross-sectional study.

  2025cites this paper
• Machine learning-driven Raman spectroscopy: A novel approach to lipid profiling in diabetic kidney disease.

  2025cites this paper
• Association of socioeconomic status with diabetic microvascular complications: a UK Biobank prospective cohort study

  2025cites this paper
• Micro and Macrovascular Complications in Diabetes Mellitus

  2025cites this paper
• Translating Basic Science to Clinical Applications: A Narrative Review of Repurposed Pharmacological Agents in Preclinical Models of Diabetic Neuropathy

  2025cites this paper
• Reduced Gastric Mucosal Innervation in Obesity: A Biomarker Predicting Remission of Diabetes After Bariatric Surgery

  2025cites this paper
• Translational control by general control nonderepressible 2 kinase regulates methylglyoxal-induced pain in mice.

  2025cites this paper
• Predictive role of weight-adjusted waist index in diabetic peripheral neuropathy among patients with type 2 diabetes mellitus

  2025cites this paper
• Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes.

  2025cites this paper
• Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations.

  2025cites this paper
• Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons

  2025cites this paper
• Modern approaches to the diagnosis of diabetic polyneuropathy: innovations and prospects

  2025cites this paper
• Mapping the research landscape of the interactions between obesity and five major complications of diabetes: a bibliometric analysis using knowledge graph visualization

  2025cites this paper
• Association between life’s simple 7 and peripheral neuropathy among U.S. adults, a cross-sectional study

  2025cites this paper
• The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database.

  2025cites this paper
• Understanding the Impact of Diabetic Peripheral Neuropathy and Neuropathic Pain on Quality of Life and Mental Health in 6,960 People With Diabetes.

  2025cites this paper
• Glycemic Targets and Prevention of Complications.

  2025cites this paper
• Risk factors for corneal nerve fiber loss in Chinese patients with type 2 diabetes mellitus.

  2025cites this paper
• Prevalence of Peripheral Neuropathy Among Very Old Adults: Evidence From the Michigan Neuropathy Screening Instrument

  2025cites this paper
• Diabetic Neuropathies

  2025cites this paper
• [Painful diabetic polyneuropathy in patients with cerebrovascular diseases].

  2025cites this paper
• The intricacies of advanced glycation end products (AGEs) in diabetic neuropathy

  2025cites this paper
• Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”

  2025cites this paper
• Development of Diagnostic Nomograms Using Corneal Nerve Parameters for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus

  2025cites this paper
• Association between low-grade inflammation and distal sensorimotor polyneuropathy in type 2 diabetes: a cross-sectional study

  2025cites this paper
• Effect of high-intensity laser versus moderate-intensity aerobic exercise on diabetic polyneuropathy patients

  2025cites this paper
• J-Shaped Relationship Between Visceral Fat Area and Large-Nerve Fiber Dysfunction Estimated by Vibration Perception Threshold in Type 2 Diabetes: A Cross-Sectional Study

  2025cites this paper
• Association of serum magnesium level with small fiber neuropathy in patients with type 2 diabetes

  2025cites this paper
• The Combination of Neurotropic Vitamins B1, B6, and B12 Enhances Neural Cell Maturation and Connectivity Superior to Single B Vitamins

  2025cites this paper
• Racial and Ethnic Differences in Peripheral Neuropathy Risk Factors Among United States Adults.

  2025cites this paper
• Proporción de polineuropatía diabética y sus posibles factores asociados

  2025cites this paper
• Lipid metabolism alterations in peripheral neuropathies.

  2025cites this paper
• Diabetic Neuropathy Part 1: Overview and Symmetric Phenotypes.

  2025cites this paper
• Corneal microstructural changes, and nephropathy, in participants with diabetes mellitus with and without peripheral neuropathy: a systematic review and meta-analysis.

  2025cites this paper
• Methylglyoxal alters C-fibre Activity-Dependent Slowing and Induces Heat Hyperalgesia in a Sex-Dependent Manner

  2025cites this paper
• Lipid Levels and Risk of Diabetic Polyneuropathy in 2 Danish Type 2 Diabetes Cohorts

  2024cites this paper
• Genetic Variants Influence the Development of Diabetic Neuropathy

  2024influential citation
• Serum Spexin Level Is Negatively Associated With Peripheral Neuropathy and Sensory Pain in Type 2 Diabetes

  2024cites this paper
• Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 Diabetes

  2024cites this paper
• Screening for diabetic peripheral neuropathy at community pharmacies in Slovakia

  2024cites this paper
• Open-label observational study of effectiveness and tolerability of ipidacrine in treatment of patients with diabetic polyneuropathy (DIAMANT study)

  2024cites this paper
• Serum C-reactive protein to albumin ratio as a reliable marker of diabetic neuropathy in type 2 diabetes mellitus

  2024cites this paper
• Investigating the Interplay between Mitophagy and Diabetic Neuropathy: Uncovering the hidden secrets of the disease pathology.

  2024cites this paper
• Neuropatie nei diabetici

  2024cites this paper
• Diabetic peripheral neuropathy: age-stratified glycemic control

  2024cites this paper
• Risk Factors for Subclinical Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus

  2024cites this paper
• Comprehensive Factors for Predicting the Complications of Diabetes Mellitus: A Systematic Review

  2024influential citation
• An Overview on Diabetic Neuropathy.

  2024cites this paper
• Diabetic Sensorimotor Polyneuropathy: An Overview on Epidemiology, Risk Factors, Classification, Diagnosis, and Treatment.

  2024cites this paper
• Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic.

  2024cites this paper
• Neuropathies chez les diabétiques

  2024cites this paper
• Neuropathy and the metabolic syndrome

  2024cites this paper
• The global and regional burden of diabetic peripheral neuropathy

  2024cites this paper
• Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes

  2024cites this paper
• 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2025.

  2024cites this paper
• Cutaneous Carbonyl Stress Is Associated With Nerve Dysfunction in Recent-Onset Type 2 Diabetes.

  2024cites this paper
• Sheffield One‐Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes

  2024cites this paper
• Trajectories of Remnant Cholesterol are Associated with Diabetic Foot Ulcer in Adult Patients with Type 2 Diabetes: A Retrospective Cohort Study

  2024cites this paper
• Diabetes and Parkinson’s Disease: Understanding Shared Molecular Mechanisms

  2024cites this paper
• High-intensity interval training, caloric restriction, or their combination have beneficial effects on metabolically acquired peripheral neuropathy.

  2024cites this paper
• Diabetic Neuropathy: Pathophysiology Review

  2024cites this paper
• Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes

  2024cites this paper
• Advances of traditional Chinese medicine preclinical mechanisms and clinical studies on diabetic peripheral neuropathy

  2024cites this paper
• Spectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment.

  2024cites this paper
• Prediction Model for Polyneuropathy in Recent‐Onset Diabetes Based on Serum Neurofilament Light Chain, Fibroblast Growth Factor‐19 and Standard Anthropometric and Clinical Variables

  2024cites this paper
• Cardiovascular autonomic and peripheral sensory neuropathy in women with obesity

  2024cites this paper
• The Role of Serum Methylglyoxal and Glyoxalase 1 on Diabetic Peripheral Neuropathy

  2023cites this paper
• Associations of polyneuropathy with risk of all‐cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status

  2023cites this paper
• Study on risk factors of diabetic peripheral neuropathy and establishment of a prediction model by machine learning

  2023cites this paper
• The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity.

  2023cites this paper
• Facteurs de risque de la neuropathie périphérique patente chez le diabétique de type 2 dans une population algérienne : principaux déterminants

  2023cites this paper
• Diabetic neuropathy: Past, present, and future

  2023cites this paper
• New perspectives in diabetic neuropathy.

  2023cites this paper
• Long-term complications of significant weight loss: lessons learned from bariatric surgery

  2023cites this paper
• The determinants of complication trajectories in American Indians with type 2 diabetes

  2023cites this paper
• Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options

  2023cites this paper
• Potential predictive biomarker for diabetic peripheral neuropathy: serum neuron-specific enolase

  2023cites this paper
• 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024.

  2023cites this paper
• Clinical Practice Guideline: Shared Decision Making, Diagnostic Evaluation, and Pharmacotherapy in Type 2 Diabetes. National Disease Management Guideline.

  2023cites this paper
• Development and validation of a risk prediction model for early diabetic peripheral neuropathy based on a systematic review and meta-analysis

  2023cites this paper
• Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decreases ISR activation in DRG neurons

  2023cites this paper
• Why too soon? Predictors of time to diabetic peripheral neuropathy among newly diagnosed diabetes mellitus patients: a multicenter follow-up study at health-care setting of Ethiopia

  2023influential citation
• Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study

  2023cites this paper
• Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study

  2023cites this paper
• A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument

  2023cites this paper
• Vascular complications of diabetes: A narrative review

  2023cites this paper
• Diabetes-Related Microvascular Complications in Primary Health Care Settings in the West Bank, Palestine

  2023cites this paper
• Advances in diagnosis and management of distal sensory polyneuropathies

  2023cites this paper
• Glyoxalase I is a novel target for the prevention of metabolic derangement.

  2023cites this paper
• Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysis

  2023cites this paper
• Painful diabetic polyneuropathy: modern approaches to diagnosis and treatment

  2023cites this paper
• Evaluation of sympathetic skin response for early diagnosis and follow-up of diabetic peripheral neuropathy in children

  2023cites this paper
• Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes

  2022cites this paper
• The conundrum of diabetic neuropathies-Past, present, and future.

  2022cites this paper
• Dicarbonyl Stress in Diabetic Vascular Disease

  2022influential citation
• Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetes

  2022cites this paper